1. GlaxoSmithKline, Wavre, Belgium
2. Hospital Universitario 12 de Octubre, Madrid, Spain
3. GlaxoSmithKline, Rixensart, Belgium
4. CureVac AG, Tübingen, Germany
5. University Hospital of Montpellier, Montpellier, France
6. Hospital Ramón y Cajal, Madrid, Spain
7. Ege University Medical School, Izmir, Turkey
8. Charles University Hospital, Prague, Czech Republic
9. Rambam Health Care Campus, Haifa, Israel
10. Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts
11. Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
12. Chonnam National University Hwasun Hospital, Jellanamdo, Republic of Korea
13. University of Kansas Cancer Center, Westwood
14. Hospital Clínico Universitario, School of Medicine, University of Valencia, Valencia, Spain
15. Centro Integral Oncológico Clara Campal (CIOCC), Universidad CEU San Pablo, Madrid, Spain
16. Weill Medical College of Cornell University, New York, New York
17. Department of Hematology and Oncology, Charité University Medical Center, Berlin, Germany
18. Preventive Medicine and Epidemiology Department, University Hospital Vall d’Hebron, Barcelona, Spain
19. Haematology Department, Manchester University NHS Foundation Trust, Manchester Royal Infirmary, Manchester, England
20. Faculty of Biology, Medicine and Health, School of Medical Science, Division of Cancer Sciences, University of Manchester, Manchester, England
21. Hospital de Donostia, San Sebastián, Spain
22. Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea
23. Hospital Ampang, Selangor, Malaysia
24. Royal Hobart Hospital, Hobart, Australia
25. Department of Clinical Haematology, Austin Health, Heidelberg, Australia
26. Fred Hutchinson Cancer Research Center, Seattle, Washington
27. Halozyme Therapeutics, San Diego, California
28. University of Pennsylvania, Philadelphia
29. Duke University Medical Center, Durham, North Carolina